All stocks ยท MOLBIO
MD

MOLBIO DIAGNOSTICS LIMITED

MOLBIO BSE Medical Devices Healthcare

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and โ€ฆ

ISIN INE869T01028
Listed โ€”
Quarters tracked 3
Filings 5 docs

About

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.

Key Metrics

as of Sep 2026
Market Cap13,388 Cr
P/E80.10
Div Yield0.00 %
Book Valueโ€”
52w Highโ‚น1,265.00
52w Lowโ‚น926.00
Face Valueโ‚น1.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Jun 2025
Sales 399.00 439.00 95.00
Expenses 308.00 332.00 105.00
Operating Profit 92.00 107.00 -10.00
OPM % 23.00 24.00 -10.00
Other Income 1.00 3.00 1.00
Depreciation 8.00 10.00 7.00
Interest 9.00 9.00 2.00
Profit before tax 76.00 91.00 -17.00
Tax % 25.00 28.00 -23.00
Net Profit 57.00 66.00 -13.00
EPS in Rs 5.02 5.83 -5.95

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales 1,313.00971.00756.00327.00776.001,271.00
Expenses 1,062.00746.00552.00286.00457.00676.00
Operating Profit 252.00226.00204.0040.00319.00595.00
OPM % 19.0023.0027.0012.0041.0047.00
Other Income 5.00-2.00-21.008.005.001.00
Interest 23.009.008.006.0025.0035.00
Depreciation 36.0026.0024.0019.0042.0012.00
Profit before tax 198.00188.00152.0023.00258.00549.00
Tax % 27.0026.0027.0032.0027.0025.00
Net Profit 145.00140.00111.0016.00187.00410.00
EPS in Rs 12.8362.00493.0169.00833.372,027.06
Dividend Payout % 0.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Equity Capital 2.002.002.002.002.00
Reserves 988.00848.00737.00681.00333.00
Borrowings 26.0070.0057.00105.00257.00
Other Liabilities 291.00157.00123.0085.00215.00
Total Liabilities 1,307.001,077.00920.00874.00806.00
Fixed Assets 215.00209.00189.00182.0055.00
CWIP 18.002.000.000.00100.00
Investments 95.0054.0054.009.009.00
Other Assets 980.00813.00676.00683.00643.00
Total Assets 1,307.001,077.00920.00874.00806.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Cash from Operating Activity 249.0038.0068.0098.00344.00
Cash from Investing Activity -98.00-31.00-51.00-87.00-142.00
Cash from Financing Activity -17.00-24.0031.00-20.00-192.00
Net Cash Flow 133.00-18.0048.00-9.0010.00
Free Cash Flow 206.0024.0055.0035.00212.00
CFO/OP % 139.0039.00251.0053.0078.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debtor Days 86.00174.00194.00113.0061.00
Inventory Days 395.00393.00885.00402.00261.00
Days Payable 226.00129.00201.0064.00124.00
Cash Conversion Cycle 254.00438.00877.00450.00198.00
Working Capital Days 155.00239.00479.00206.0075.00
ROCE % 21.0022.004.0041.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Aug 2026
Promoters 41.29
FIIs 1.51
DIIs 16.36
Public 40.83
No. of Shareholders 233,544

Corporate Actions

No corporate actions recorded.

Announcements

5 filings